use of tirzepatide The science tirzepatide, touted as a game-changing weight loss drug Tirzepatide vs. Semaglutide: Which Is

Combination with SGLT2 inhibitors to augment the benefits of this drug class in HFrEF with, for example, the weight-lowering effects of GLP-1 RA could offer a clinically valuable and feasible option addressing the spectrum of abnormalities associated with this HF phenotype

Airway protection is important in immediate management, and antihistamines, corticosteroids, or sympathomimetics such as epinephrine can be administered if severe

Ozempic slows gastric emptying, so individuals may need to adjust their meal timing and composition to minimize gastrointestinal side effects

Additional tests are usually unnecessary

In individuals with overweight or obesity, treatment with semaglutide was associated with significant reductions in bodyweight, with a mean placebo-subtracted weight loss of 12.4% relative to placebo after 68 weeks reported in the STEP 1 trial